Le Lézard
Classified in: Health
Subject: OBI

Statement from University Health Network on the death of Peter Munk


TORONTO, March 28, 2018 /CNW/ - Mr. Peter Munk has been one of the hospital's most influential and loyal supporters for many years, serving on the Board of Trustees of the hospital, acting as an advisor to many of the hospital's leaders, and supporting the creation, evolution and growth of the Peter Munk Cardiac Centre.

Peter Munk (CNW Group/University Health Network)

"On behalf of everyone at University Health Network (UHN) and the Peter Munk Cardiac Centre, I would like to extend my condolences to the Munk family," said Dr. Charlie Chan, Interim President and CEO ? UHN.  "Peter has been a good friend to so many of us at the hospital and his vision for what could be accomplished within Canadian healthcare inspired us all."

Dr. Barry Rubin, Medical Director of the Peter Munk Cardiac Centre, worked closely with Mr. Munk and his wife, Melanie Munk, to advance their shared vision for the Cardiac Centre.  Their relationship has done much to make the Peter Munk Cardiac Centre one of the world's leaders in cardiovascular care.

"While we have lost a great friend, Mr. Munk's vision to provide outstanding, compassionate care for patients with cardiac and vascular disease will live on through the Peter Munk Cardiac Centre.  Through Mr. Munk's incredible generosity, we will continue to work towards achieving the level of excellence in patient care, teaching and research that Mr. Munk expected.  This is a legacy that all Canadians should be proud of."

A summary of Mr. Munk's involvement with UHN and the Peter Munk Cardiac Centre may be found here.  This material, including the speech given by Mr. Munk at the September 19, 2017 event marking the largest single gift every given to a Canadian hospital, is a testament to Mr. Munk's passion for Canada and his drive to ensure that Canadian clinical care, education and science were fully supported when it came to matters of the heart.

SOURCE University Health Network


These press releases may also interest you

at 07:35
Agenus Inc. ("Agenus") , a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Agenus executives...

at 07:34
Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An," the "Company" or the "Group," HKEX: 2318; SSE: 601318) today announced its first quarter financial results for the three months ended March 31, 2024....

at 07:31
Tharimmune, Inc. ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation & immunology, announced today an option agreement for an...

at 07:30
KFSH&RC participates as a strategic partner in the Saudi American Healthcare Forum, which will take place on April 25th under the patronage of the Ministry of Health in Riyadh. This forum aims to discuss the primary healthcare challenges facing the...

at 07:30
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on...

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....



News published on and distributed by: